249 related articles for article (PubMed ID: 30551354)
1. Tetramethylpyrazine (TMP) ameliorates corneal neovascularization via regulating cell infiltration into cornea after alkali burn.
Wu Y; Xu Z; Yang Y; Qiu J; Yang M; Wu C; Lai Z; Tang M; Ge J; Yu K; Zhuang J
Biomed Pharmacother; 2019 Jan; 109():1041-1051. PubMed ID: 30551354
[TBL] [Abstract][Full Text] [Related]
2. Tetramethylpyrazine in a Murine Alkali-Burn Model Blocks NFκB/NRF-1/CXCR4-Signaling-Induced Corneal Neovascularization.
Tang M; Yang Y; Yu J; Qiu J; Chen P; Wu Y; Wang Q; Xu Z; Ge J; Yu K; Zhuang J
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):2133-2141. PubMed ID: 29801148
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1/CXCR4 axis.
Cai X; Chen Z; Pan X; Xia L; Chen P; Yang Y; Hu H; Zhang J; Li K; Ge J; Yu K; Zhuang J
PLoS One; 2014; 9(2):e88176. PubMed ID: 24505417
[TBL] [Abstract][Full Text] [Related]
4. Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model.
Yu J; Shen Y; Luo J; Jin J; Li P; Feng P; Guan H
Int Immunopharmacol; 2023 Mar; 116():109680. PubMed ID: 36739832
[TBL] [Abstract][Full Text] [Related]
5. Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.
Shen M; Zhou XZ; Ye L; Yuan Q; Shi C; Zhu PW; Jiang N; Ma MY; Yang QC; Shao Y
Int J Mol Med; 2018 Aug; 42(2):769-778. PubMed ID: 29717775
[TBL] [Abstract][Full Text] [Related]
6. The role of pirfenidone in alkali burn rat cornea.
Jiang N; Ma M; Li Y; Su T; Zhou XZ; Ye L; Yuan Q; Zhu P; Min Y; Shi W; Xu X; Lv J; Shao Y
Int Immunopharmacol; 2018 Nov; 64():78-85. PubMed ID: 30153530
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
Kim JW; Jeong H; Yang MS; Lim CW; Kim B
Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
[TBL] [Abstract][Full Text] [Related]
8. AIP1 suppresses neovascularization by inhibiting the NOX4-induced NLRP3/NLRP6 imbalance in a murine corneal alkali burn model.
Li Q; Hua X; Li L; Zhou X; Tian Y; Deng Y; Zhang M; Yuan X; Chi W
Cell Commun Signal; 2022 May; 20(1):59. PubMed ID: 35524333
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin inhibits corneal inflammatory response and neovascularization in a mouse model of corneal alkali burn.
Li J; Han J; Shi Y; Liu M
Exp Eye Res; 2023 Aug; 233():109539. PubMed ID: 37315833
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn.
Arima T; Uchiyama M; Nakano Y; Nagasaka S; Kang D; Shimizu A; Takahashi H
Sci Rep; 2017 Dec; 7(1):17763. PubMed ID: 29259285
[TBL] [Abstract][Full Text] [Related]
11. Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization.
Liu G; Lu P; Li L; Jin H; He X; Mukaida N; Zhang X
Mol Vis; 2011; 17():2129-38. PubMed ID: 21850188
[TBL] [Abstract][Full Text] [Related]
12. Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway.
Xueying Z; Liang G; Siyi L; Fengyue LI; Mingli L; Wanting L; Chun M; Guanghui L
J Tradit Chin Med; 2024 Apr; 44(2):268-276. PubMed ID: 38504533
[TBL] [Abstract][Full Text] [Related]
13. NK1 receptor antagonists as a new treatment for corneal neovascularization.
Bignami F; Giacomini C; Lorusso A; Aramini A; Rama P; Ferrari G
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6783-94. PubMed ID: 25228541
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization.
Lee CM; Jung WK; Na G; Lee DS; Park SG; Seo SK; Yang JW; Yea SS; Lee YM; Park WS; Choi IW
Cutan Ocul Toxicol; 2015 Mar; 34(1):53-60. PubMed ID: 24754407
[TBL] [Abstract][Full Text] [Related]
15.
Estrella-Mendoza MF; Jiménez-Gómez F; López-Ornelas A; Pérez-Gutiérrez RM; Flores-Estrada J
Nutrients; 2019 May; 11(5):. PubMed ID: 31137826
[TBL] [Abstract][Full Text] [Related]
16. Daphnetin inhibits corneal inflammation and neovascularization on a mouse model of corneal alkali burn.
Yang T; Wang X; Guo L; Zheng F; Meng C; Zheng Y; Liu G
Int Immunopharmacol; 2022 Feb; 103():108434. PubMed ID: 34920334
[TBL] [Abstract][Full Text] [Related]
17. Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation.
Shin YJ; Hyon JY; Choi WS; Yi K; Chung ES; Chung TY; Wee WR
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4452-8. PubMed ID: 23716625
[TBL] [Abstract][Full Text] [Related]
18. Transient downregulation of microRNA-206 protects alkali burn injury in mouse cornea by regulating connexin 43.
Li X; Zhou H; Tang W; Guo Q; Zhang Y
Int J Clin Exp Pathol; 2015; 8(3):2719-27. PubMed ID: 26045777
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
[TBL] [Abstract][Full Text] [Related]
20. Involvement of NADPH oxidases in alkali burn-induced corneal injury.
Gu XJ; Liu X; Chen YY; Zhao Y; Xu M; Han XJ; Liu QP; Yi JL; Li JM
Int J Mol Med; 2016 Jul; 38(1):75-82. PubMed ID: 27221536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
